Field Gap

Under-studied area: Biomarker endpoint

Over-represented in the literature

Discrimination metrics (AUC, Dice) as the terminal deliverable

Under-represented

Linkage of imaging biomarkers to patient-relevant outcomes (OS/PFS causally, QoL, treatment-decision change)

Why the gap exists

Outcome linkage requires long follow-up and trial embedding; discrimination is a one-shot computation

Open in the interactive atlas →

About this page

Curated and maintained by Resonant Labs. Editorial lead: Claims are synthesized from the cited literature and graded per the Atlas methodology (about the Atlas). Page generated 2026-10-02. This is not a new clinical review date.

This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.